From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
October 31, 2018
Philadelphia, PA, October 31, 2018 – IntegriChain, a leading life sciences commercial analytics company that helps innovative bio/pharma manufacturers identify and remove barriers to patient therapy initiation and adherence, today announced that Executive Director of Solutions, David Weiss, will speak on government pricing at the scwish:pharma Conference. The scwish:pharma conference is designed for pharmaceutical manufacturers seeking actionable guidance about major industry issues and opens tomorrow in Boca Raton, FL.
Weiss’ presentation, “Critical Profitability and Compliance Considerations in Government Price Reporting,” will address best practices for creating government pricing efficiencies, an important challenge for commercialization teams to overcome. Weiss will speak on the key impact of generics and brand pricing decisions on government price reporting and future profitability and compliance, and he will review government payer trends that affect commercializing products.
“Government pricing requirements are incredibly complex with complicated calculations and confusing regulations, and many manufacturers find it overwhelming,” said Weiss. “At schwish:pharma, I will help clarify recent regulatory changes that are important and provide some insight into what pharmaceutical executives need to know about potential changes be on the horizon that could have long-term impact.”
About IntegriChain IntegriChain is a life sciences commercial analytics company that helps innovative bio/pharma manufacturers identify and remove barriers to patient therapy initiation and adherence. Our ICyte Platform and solutions uniquely focus on what happens after the patient and provider commit to therapy. More than 140 life science manufacturers rely on insights delivered from IntegriChain’s data, analytics, and managed services to drive strategic decision-making and on-going business management across their payers, specialty pharmacies, patient services, and distribution channel partners. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA; the Access Management Operations center is in Ambler, PA; and the Patient Services Center is in Atlanta, GA. For more information, visit www.integrichain.com or follow us on Twitter @IntegriChain and LinkedIn.
Contact Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | Jennifer@sagestrat.com
Save the date!
Webinars & Resources
See List
